Supplementary Figure S2 from Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration

Amei Ludwig; Zachary P. McKay; Griffin P. Carter; Mark A. Katz; Georgia Howell; Vaibhav Jain; Stephanie Arvai; Dirk P. Dittmer; Darell D. Bigner; David M. Ashley; Madison L Shoaf; Annick Desjardins; Simon G. Gregory; Michael C. Brown; Matthias Gromeier

doi:10.1158/2326-6066.31239131

Supplementary Figure S2 from Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration

2026 Open access

Read full text

Authors: Amei Ludwig, Zachary P. McKay, Griffin P. Carter, Mark A. Katz, Georgia Howell, Vaibhav Jain, Stephanie Arvai, Dirk P. Dittmer, Darell D. Bigner, David M. Ashley, Madison L Shoaf, Annick Desjardins

+3 more

Simon G. Gregory, Michael C. Brown, Matthias Gromeier

DOI: 10.1158/2326-6066.31239131

Cited by: 0

Abstract

Supplementary Figure S2. Differences in gene expression and hallmark pathways between single-site (IT or CPLI) and dual-site (IT plus CPLI) treatment cohorts compared to mock treatment as shown.

Fields of Study & Subjects

Virus-based gene therapy research Immunotherapy and Immune Responses Cancer Research and Treatments

Publication details

Publication date: 3 February 2026